Current Metabolomics
Title:Meet Our Editors
Volume: 4 Issue: 2
Author(s): Ying-Yong Zhao and Fariba Assadi-Porter
Affiliation:
Export Options
About this article
Cite this article as:
Zhao Ying-Yong and Assadi-Porter Fariba, Meet Our Editors, Current Metabolomics 2016; 4 (2) . https://dx.doi.org/10.2174/2213235X0402160630190728
DOI https://dx.doi.org/10.2174/2213235X0402160630190728 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
30
Related Articles
-
Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design Selenium and Cardiovascular Surgery: An Overview
Current Drug Safety Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
Recent Patents on Cardiovascular Drug Discovery Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Current Pharmaceutical Design Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development
Recent Patents on Anti-Cancer Drug Discovery Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications
Current Drug Targets Modulation of Ion Channels in Pulmonary Arterial Hypertension
Current Pharmaceutical Design Bryothamnion seaforthii Lectin Relaxes Vascular Smooth Muscle: Involvement of Endothelium and NO Synthase
Protein & Peptide Letters 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects
Current Drug Metabolism Effect of Non-Vegetarian Diet on Cardiovascular Reactivity to Mental Stress in Young Adults
Vascular Disease Prevention (Discontinued) Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs
Current Vascular Pharmacology Statin Treatment Non-adherence and Discontinuation: Clinical Implications and Potential Solutions
Current Pharmaceutical Design Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan
Current Drug Delivery The Potential Use of Grape Phytochemicals for Preventing the Development of Intestine-Related and Subsequent Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Determination of the Percent Composition and Mineral Content of the Leaves of the Insulin Plant (Cissus sicyoides) with the Goal of Including it in the Usual Diet
The Natural Products Journal A New Binding Site Involving the C-terminal Domain to Design Specific Inhibitors of PepX
Protein & Peptide Letters Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic Agents
Recent Patents on CNS Drug Discovery (Discontinued) Poor Response to Antiplatelet Drugs. An Important Issue in Drug-Eluting Stents.
Current Clinical Pharmacology